Abeona Therapeutics Inc.

Abeona Therapeutics Inc.verified

ABEO

Price:

$5.53

Market Cap:

$315.18M

Abeona Therapeutics Inc. is a biopharmaceutical company in the clinical development stage, focused on creating innovative gene and cell therapies to address severe and uncommon genetic diseases. Its leading program, EB-101, an autologous gene-corrected cell therapy, is presently in a Phase III clinical trial for treating recessive dystrophic epidermolysis bullosa. The company's pipeline also features several other promising therapies: ABO-102, an adeno-associated virus (AAV)-based gene therapy for Sanfilippo syndrome type A. ABO-201, intended for CLN3 disease. ABO-401, developed to treat cystic fibrosis. ABO-50X, aimed at various genetic eye disorders. Additionally, Abeona is advancing AAV-b...[Read more]

Industry

Biotechnology

IPO Date

1980-09-19

Stock Exchange

NASDAQ

Ticker

ABEO

The Enterprise Value as of June 2026 (TTM) for Abeona Therapeutics Inc. (ABEO) is 276.98M

According to Abeona Therapeutics Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 276.98M. This represents a change of 33.93% compared to the average of 206.80M of the last 4 quarters.

Abeona Therapeutics Inc. (ABEO) Historical Enterprise Value (quarterly & annually)

How has ABEO Enterprise Value performed in the past?

The mean historical Enterprise Value of Abeona Therapeutics Inc. over the last ten years is 173.37M. The current 276.98M Enterprise Value has changed 15.88% with respect to the historical average. Over the past ten years (40 quarters), ABEO's Enterprise Value was at its highest in in the June 2018 quarter at 706.81M. The Enterprise Value was at its lowest in in the December 2021 quarter at 12.04M.

Quarterly (TTM)
Annual

Average

173.37M

Median

119.84M

Minimum

9.91M

Maximum

522.01M

Abeona Therapeutics Inc. (ABEO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Abeona Therapeutics Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 456.26%

Maximum Annual Enterprise Value = 522.01M

Minimum Annual Increase = -93.00%

Minimum Annual Enterprise Value = 9.91M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2025225.59M-1.20%
2024228.33M132.89%
202398.04M456.26%
202217.62M77.80%
20219.91M-93.00%
2020141.63M226.83%
201943.34M-87.64%
2018350.58M-32.84%
2017522.01M440.34%
201696.61M70.69%

Abeona Therapeutics Inc. (ABEO) Average Enterprise Value

How has ABEO Enterprise Value performed in the past?

The current Enterprise Value of Abeona Therapeutics Inc. (ABEO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

183.99M

5-year avg

115.90M

10-year avg

173.37M

Abeona Therapeutics Inc. (ABEO) Enterprise Value vs. Peers

How is ABEO’s Enterprise Value compared to its peers?

Abeona Therapeutics Inc.’s Enterprise Value is greater than Tenaya Therapeutics, Inc. (47.82M), greater than Eledon Pharmaceuticals, Inc. (208.42M), less than Puma Biotechnology, Inc. (352.85M), greater than Humacyte, Inc. (194.60M), greater than Voyager Therapeutics, Inc. (202.73M), greater than Arcturus Therapeutics Holdings Inc. (10.72M), greater than Foghorn Therapeutics Inc. (198.51M), greater than Sagimet Biosciences Inc. (174.54M), less than Assembly Biosciences, Inc. (336.27M),

Build a custom stock screener for Abeona Therapeutics Inc. (ABEO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Abeona Therapeutics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Abeona Therapeutics Inc. (ABEO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Abeona Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Abeona Therapeutics Inc.'s Enterprise Value?

What is the highest Enterprise Value for Abeona Therapeutics Inc. (ABEO)?

What is the 3-year average Enterprise Value for Abeona Therapeutics Inc. (ABEO)?

What is the 5-year average Enterprise Value for Abeona Therapeutics Inc. (ABEO)?

How does the current Enterprise Value for Abeona Therapeutics Inc. (ABEO) compare to its historical average?